Corticotrophin secretion capacity in multiple sclerosis.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000208:Acute Disease; D000324:Adrenocorticotropic Hormone / Q000378:metabolism* / Q000652:urine; D000328:Adult; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D008297:Male; D008797:Metyrapone; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000378:metabolism* / Q000473:pathology; D009461:Neurologic Manifestations; D010912:Pituitary-Adrenal Function Tests; D010913:Pituitary-Adrenal System; D013268:Stimulation, Chemical; D014667:Vasopressins
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D014667:Vasopressins; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone